JESSICA RYDER: Open Payments
NPI 1033371307 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,834 in 91 payments from 14 companies in 2025. Trend: 2023 $1,073 · 2024 $1,192 · 2025 $1,834
Food & beverage: $1,783Education: $51
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $654 |
| ABBVIE INC. | 26 | $326 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $153 |
| GENZYME CORPORATION | 9 | $146 |
| Novo Nordisk Inc | 2 | $140 |
| QOL Medical, LLC | 4 | $82 |
| Gilead Sciences, Inc. | 3 | $81 |
| Phathom Pharmaceuticals, Inc. | 1 | $74 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| PFIZER INC. | 2 | $37 |
Products named: TREMFYA, RINVOQ, XIFAXAN, DUPIXENT, Wegovy, Sucraid, VOQUEZNA, SKYRIZI.
Industry payments across NM — which companies pay providers there.
